Hemenway Trust Hemenway Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,248
Closed -$392K 136
2024
Q2
$392K Sell
4,248
-2,850
-40% -$252K 0.03% 94
2024
Q1
$678K Sell
7,098
-12,382
-64% -$1.04M 0.06% 77
2023
Q4
$1.49M Sell
19,480
-31,293
-62% -$2.18M 0.14% 54
2023
Q3
$3.52M Buy
50,773
+1,867
+4% +$150K 0.37% 41
2023
Q2
$4.61M Sell
48,906
-354
-0.7% -$30.8K 0.45% 39
2023
Q1
$4.08M Buy
49,260
+5,722
+13% +$450K 0.43% 40
2022
Q4
$3.25M Sell
43,538
-48,590
-53% -$3.74M 0.36% 44
2022
Q3
$7.61M Buy
92,128
+1,230
+1% +$118K 0.89% 37
2022
Q2
$8.64M Buy
90,898
+19,779
+28% +$2.05M 0.98% 36
2022
Q1
$8.37M Buy
71,119
+24,104
+51% +$2.7M 0.8% 38
2021
Q4
$6.09M Buy
47,015
+34,866
+287% +$4.07M 0.55% 41
2021
Q3
$1.38M Buy
+12,149
New +$1.39M 0.14% 61

Other funds holding EW

Hemenway Trust Hemenway Trust's EW Position: Q3 2024 in Review

Hemenway Trust Hemenway Trust sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 4,248 shares — an estimated $392K sold.

Hemenway Trust Hemenway Trust first reported a position in EW in Q3 2021 and held it in 12 quarters. The position peaked at $8.64M in Q2 2022. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Hemenway Trust Hemenway Trust reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 4,248 Edwards Lifesciences shares in Q3 2024, an estimated $392K.
  • Hemenway Trust Hemenway Trust first reported a position in Edwards Lifesciences in Q3 2021 and held it in 12 quarters.
  • Hemenway Trust Hemenway Trust's Edwards Lifesciences position peaked at $8.64M in Q2 2022.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q3 2024, filed 5 Nov 2024.